Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-511X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study ; volume:21 ; number:1 ; day:2 ; month:7 ; year:2022 ; pages:1-7 ; date:12.2022
Lipids in health and disease ; 21, Heft 1 (2.7.2022), 1-7, 12.2022
- Urheber
-
Kjærgaard, Kasper Aalbæk
Harborg, Sixten
Jensen, Henrik Kjærulf
Borgquist, Signe
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12944-022-01666-2
- URN
-
urn:nbn:de:101:1-2022082220401198804838
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kjærgaard, Kasper Aalbæk
- Harborg, Sixten
- Jensen, Henrik Kjærulf
- Borgquist, Signe
- SpringerLink (Online service)
Ähnliche Objekte (12)
P5.22: Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
Familial Hypercholesterolemia: new therapeutic approaches
Sex Differences in Familial Hypercholesterolemia
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia: Present and Future Management
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study
Current causes of death in familial hypercholesterolemia
Familial hypercholesterolemia in very young myocardial infarction
Deploying Clinical Decision Support for Familial Hypercholesterolemia
P5.22: Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
Familial Hypercholesterolemia: new therapeutic approaches
Sex Differences in Familial Hypercholesterolemia
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia: Present and Future Management
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study
Current causes of death in familial hypercholesterolemia
Familial hypercholesterolemia in very young myocardial infarction
Deploying Clinical Decision Support for Familial Hypercholesterolemia
P5.22: Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
Familial Hypercholesterolemia: new therapeutic approaches
Sex Differences in Familial Hypercholesterolemia
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia: Present and Future Management
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study
Current causes of death in familial hypercholesterolemia
Familial hypercholesterolemia in very young myocardial infarction